Company Overview - Meili Tianyuan Medical Health reported a total revenue of 2.572 billion yuan for the year ending December 31, 2024, representing a year-on-year growth of 19.91% [1] - The net profit attributable to the parent company was 228 million yuan, with a year-on-year increase of 5.94% [1] - The gross profit margin stood at 46.26%, while the debt-to-asset ratio was 77.2% [1] Stock Performance - As of May 22, the stock price of Meili Tianyuan Medical Health closed at 19.3 HKD per share, reflecting a rise of 7.34% with a trading volume of 779,000 shares and a turnover of 14.57 million HKD [1] - Over the past month, the stock has seen a cumulative increase of 7.66%, but year-to-date, it has only risen by 1.01%, underperforming the Hang Seng Index by 18.78% [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -21.43 times, with a median of 0.3 times [2] - Meili Tianyuan Medical Health has a P/E ratio of 17.18 times, ranking 29th in the industry [2] - Other companies in the sector have varying P/E ratios, with Juxing Medical Holdings at 0.23 times, Jingjiu Health at 0.38 times, Yongsheng Medical at 3.97 times, Global Medical at 4.67 times, and Ruici Medical at 5.5 times [2] Company Background - Established in 1993, Meili Tianyuan is one of the long-standing domestic chain brands in China's beauty and health management service industry [2] - The company has developed three emerging brands: Beili Shi, Yanyuan, and Xiuker [2] - As of June 30, 2022, the company operates a service network of 352 stores, including 177 directly operated and 175 franchised stores, covering 100 cities nationwide [2]